TES Pharma S.r.l., Via P. Togliatti, 20, Loc Taverne, 06073 Corciano, Italy.
Molecules. 2013 Aug 30;18(9):10497-513. doi: 10.3390/molecules180910497.
Bile acids have emerged as versatile signalling compounds of a complex network of nuclear and membrane receptors regulating various endocrine and paracrine functions. The elucidation of the interconnection between the biological pathways under the bile acid control and manifestations of hepatic and metabolic diseases have extended the scope of this class of steroids for in vivo investigations. In this framework, the design and synthesis of novel biliary derivatives able to modulate a specific receptor requires a deep understanding of both structure-activity and structure-property relationships of bile acids. In this paper, we report the preparation and the critical micellization concentration evaluation of a series of hyodeoxycholic acid derivatives characterized by a diverse side chain length and by the presence of a methyl group at the alpha position with respect to the terminal carboxylic acid moiety. The data collected are instrumental to extend on a quantitative basis, the knowledge of the current structure-property relationships of bile acids and will be fruitful, in combination with models of receptor activity, to design and prioritize the synthesis of novel pharmacokinetically suitable ligands useful in the validation of bile acid-responsive receptors as therapeutic targets.
胆汁酸已成为调节各种内分泌和旁分泌功能的核受体和膜受体复杂网络中多功能的信号化合物。阐明受胆汁酸控制的生物途径之间的相互联系以及肝和代谢性疾病的表现,已经扩展了这类甾体激素在体内研究的范围。在这一框架内,设计和合成能够调节特定受体的新型胆汁酸衍生物,需要深入了解胆汁酸的结构-活性和结构-性质关系。在本文中,我们报告了一系列猪去氧胆酸衍生物的制备和临界胶束浓度评估,这些衍生物具有不同的侧链长度,并且在末端羧酸部分的α位具有一个甲基。所收集的数据对于在定量基础上扩展胆汁酸的现有结构-性质关系是有帮助的,并且与受体活性模型结合,将有助于设计和优先合成新型药代动力学合适的配体,这些配体可用于验证胆汁酸反应性受体作为治疗靶点。